F 92502 CN
Latest Information Update: 26 Mar 1998
Price :
$50 *
At a glance
- Originator FAES Farma
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 26 Mar 1998 Discontinued-Preclinical for Anxiety disorders in Spain (PO)
- 15 May 1995 Preclinical development for Anxiety disorders in Spain (PO)